PLWH	People living with HIV
ART	Antiretroviral therapy
OI	Opportunistic infections
Mtb	Mycobacterium tuberculosis
MAC	Mycobacterium avium complex
CMV	Cytomegalovirus
KSHV	Kaposi sarcoma associated herpesvirus
HCV	Hepatitis C virus
HBV	Hepatitis B virus
IRIS	Immune Reconstitution Inflammatory Syndrome
SI	Systemic inflammation
NICMs	Noninfectious comorbidities
IL	Interleukin
TNF	Tissue necrosis factor
CRP	C-reactive protein
TLR	Toll-like receptors
AIDS	Acquired Immunodeficiency Syndrome
HLA	Human leukocyte antigen
CXCR	chemokine receptor
LBP	Lipopolysaccharide-binding protein
CXCL	C-X-C motif chemokine ligand
CCL	C–C motif chemokine ligand
PD	Programmed cell death receptor
CTLA	Cytotoxic T-lymphocyte-associated protein
LAG	Lymphocyte-activation gene
OXPHOS	Oxidative phosphorylation
ATP	Adenosine triphosphate
GLUT	Glucose transporter
HAND	HIV-associated neurocognitive disorder
CKD	Chronic kidney diseases
CVD	Cardiovascular disease
TF	Tissue factor
PAR	Protease activated receptor
WHO	World Health Organization
MIP	Macrophage inflammatory protein
HIF	Hypoxia-inducible factor
IFN	Interferon
MMPs	Matrix metalloproteinases
TIMP	tissue inhibitors of metalloproteinases
TB-IRIS	tuberculosis-associated immune reconstitution inflammatory syndrome
M-IRIS	Mycobacterial IRIS
C-IRIS	Cryptococcus IRIS
VZV	Varicella-zoster virus
EOD	End-organ diseases
HHV	Human herpesvirus
CSF	Cerebrospinal fluid
PJP	Pneumocystis pneumonia
LTA4H	leukotriene A4 hydroxylase
KIR	killer-cell immunoglobulin-like receptors
BMI	Body mass index
DTG	Dolutegravir
INSPIRING	International Study of Patients with HIV on Rifampicin ING